The impairment of insulin signaling in Alzheimer's disease

被引：69

作者：

Candeias, Emanuel ^{[1
]}

Duarte, Ana I. ^{[1
]}

Carvalho, Cristina ^{[1
,2
]}

Correia, Sonia C. ^{[1
,2
]}

Cardoso, Susana ^{[1
,2
]}

Santos, Renato X. ^{[1
,2
]}

Placido, Ana I. ^{[1
]}

Perry, George ^{[4
]}

Moreira, Paula I. ^{[1
,3
]}

机构：

[1] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal

[2] Univ Coimbra, Fac Sci & Technol, Dept Life Sci, P-3004517 Coimbra, Portugal

[3] Univ Coimbra, Fac Med, Physiol Lab, P-3004517 Coimbra, Portugal

[4] Univ Texas San Antonio, Coll Sci, San Antonio, TX USA

来源：

IUBMB LIFE | 2012年 / 64卷 / 12期

关键词：

aging; Alzheimer's disease; type; 2; diabetes; insulin signaling; THERAPEUTIC TARGET; GLUCOSE-METABOLISM; BRAIN; RESISTANCE; MITOCHONDRIA; DYSFUNCTION; DEMENTIA; RECEPTOR; PATHWAY; RISK;

D O I：

10.1002/iub.1098

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Alterations of the insulin signaling cascade underlie cognitive decline and the development of several neurodegenerative diseases. In recent years, a great interest has been put in studying the interaction between diabetes and Alzheimer's disease (AD). In fact, evidence shows that both diseases present several biochemical similarities including defects in the insulin signaling pathway. Here, we give an overview of the main functions of insulin in the central nervous system. The impact of insulin signaling impairment in brain aging and AD is also discussed. Finally, we present evidence supporting the notion that insulin is a link between diabetes and AD. (C) 2012 IUBMB IUBMB Life, 64(12): 951957, 2012

引用

页码：951 / 957

页数：7

共 50 条

[21] Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease
Hoelscher, Christian
[J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2011, 39 : 891 - 897
[22] Evidence of disturbed insulin signaling in animal models of Alzheimer's disease
Alves, Suelen Santos
Servilha-Menezes, Gabriel
Rossi, Leticia
da Silva Junior, Rui Milton Patricio
Garcia-Cairasco, Norberto
[J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2023, 152
[23] Insulin signaling as a therapeutic target in Alzheimer's disease: Efficacy of apomorphine
Ohyagi, Yasumasa
Takei, Satoko I.
[J]. NEUROLOGY AND CLINICAL NEUROSCIENCE, 2020, 8 (03): : 146 - 154
[24] INTRANASAL DELIVERY OF INSULIN FOR THE RESTORATION OF MEMORY SIGNALING IN ALZHEIMER'S DISEASE
Nema, T.
Bhargava, S.
[J]. PARKINSONISM & RELATED DISORDERS, 2024, 122
[25] Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease
Pardeshi, Rohit
Bolshette, Nityanand
Gadhave, Kundlik
Ahire, Ashutosh
Ahmed, Sahabuddin
Cassano, Tommaso
Gupta, Veer Bala
Lahkar, Mangala
[J]. PSYCHONEUROENDOCRINOLOGY, 2017, 83 : 159 - 171
[26] Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease
Ferreira, Sergio T.
Clarke, Julia R.
Bomfim, Theresa R.
De Felice, Fernanda G.
[J]. ALZHEIMERS & DEMENTIA, 2014, 10 : S76 - S83
[27] Brain insulin signaling and Tau: impact for Alzheimer's disease and Tauopathies
Joly-Amado, Aurelie
Gratuze, Maud
Benderradji, Hamza
Vieau, Didier
Buee, Luc
Blum, David
[J]. M S-MEDECINE SCIENCES, 2018, 34 (11): : 929 - 935
[28] Intranasal delivery of insulin for the restoration of memory signaling in Alzheimer's disease
Bhargava, Mani
Bhargava, Saurabh
[J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 118 - 119
[29] Insulin and Alzheimer's disease
Holt, Richard I. G.
[J]. DIABETES OBESITY & METABOLISM, 2007, 9 (04): : 607 - 607
[30] Incretin and insulin signaling as novel therapeutic targets for Alzheimer's and Parkinson's disease
Nowell, Joseph
Blunt, Eleanor
Edison, Paul
[J]. MOLECULAR PSYCHIATRY, 2023, 28 (01) : 217 - 229

← 1 2 3 4 5 →